Intellia Therapeutics, Inc. (NTLA) vs Ocular Therapeutix, Inc. (OCUL)
A side-by-side comparison of Intellia Therapeutics, Inc. and Ocular Therapeutix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NTLA
Intellia Therapeutics, Inc.
$12.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OCUL
Ocular Therapeutix, Inc.
$7.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NTLA vs OCUL
growth of $100 · dividends reinvested · last 10yNTLA -26.5% (-3.0%/yr)OCUL +5.8% (+0.6%/yr)OCUL compounded faster over this window
NTLA OCUL
NTLA vs OCUL: by the numbers
- •NTLA is the larger company ($1.73B vs $1.61B market cap).
- •Both run net losses; OCUL's is the smaller (-579.10% vs -672.16% net margin).
- •OCUL grew revenue faster over the past five years (10.03% vs 7.31% CAGR).
Metrics side by side
Valuation
| Metric | NTLA | OCUL |
|---|---|---|
| P/S ratio | 29.05 | 30.87 |
| P/B ratio | 2.38 | 3.09 |
Profitability
| Metric | NTLA | OCUL |
|---|---|---|
| Gross margin | 76.47% | 87.11% |
| Operating margin | -651.67% | -521.04% |
| Net margin | -672.16% | -579.10% |
| ROE | -54.96% | -57.97% |
| ROIC | -54.45% | -50.20% |
Growth (annualized)
| Metric | NTLA | OCUL |
|---|---|---|
| Revenue CAGR (5Y) | 7.31% | 10.03% |
| Total return CAGR (5Y) | -37.13% | -5.73% |
Frequently asked
- Which has grown faster, NTLA or OCUL?
- Over the past five years, OCUL grew revenue faster — NTLA at a 7.31% CAGR versus OCUL at 10.03%.
- How have NTLA and OCUL total returns compared?
- Over the past 10 years, NTLA delivered -3.03% and OCUL delivered 0.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.